KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Asset Writedowns and Impairment (2017 - 2026)

Cardlytics filings provide 10 years of Asset Writedowns and Impairment readings, the most recent being $335000.0 for Q1 2026.

  • Quarterly Asset Writedowns and Impairment fell 47.9% to $335000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.7 million through Mar 2026, down 97.28% year-over-year, with the annual reading at $2.1 million for FY2025, 98.38% down from the prior year.
  • Asset Writedowns and Impairment hit $335000.0 in Q1 2026 for Cardlytics, up from -$56.7 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $131.6 million in Q3 2024 and bottomed at -$56.7 million in Q4 2025.
  • Average Asset Writedowns and Impairment over 5 years is $13.3 million, with a median of $842500.0 recorded in 2022.
  • The largest annual shift saw Asset Writedowns and Impairment tumbled 171.1% in 2023 before it skyrocketed 32074.82% in 2024.
  • Cardlytics' Asset Writedowns and Impairment stood at $1.4 million in 2022, then skyrocketed by 4683.79% to $69.4 million in 2023, then soared by 89.71% to $131.6 million in 2024, then crashed by 143.09% to -$56.7 million in 2025, then surged by 100.59% to $335000.0 in 2026.
  • Per Business Quant, the three most recent readings for CDLX's Asset Writedowns and Impairment are $335000.0 (Q1 2026), -$56.7 million (Q4 2025), and $58.8 million (Q3 2025).